Spirig Pharma Ltd.: Clinical Trials

3 trials sponsored by Spirig Pharma Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1
Phase 11Terminated 1

Follow Spirig Pharma Ltd.: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis
Sertaconazole 2% cream, Placebo - Skin Alterations Associated With Atopic Dermatitis
Phase 2CompletedSpirig Pharma Ltd.702013-02-012015-05-20
Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma
0.06% Resiquimod Gel - A, 0.06% Resiquimod Gel - B, 0.06% Resiquimod Gel - C - Nodular Basal Cell Carcinoma
Phase 1 / Phase 2TerminatedSpirig Pharma Ltd.42013-02-012016-06-22
Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions
Resiquimod 0.03%, Resiquimod 0.01%, placebo - Actinic Keratosis
Phase 2CompletedSpirig Pharma Ltd.2182012-05-012015-12-15

Conditions studied

Dermatitis, Atopic (1)  ·  Keratosis, Actinic (1)

Interventions

sertaconazole (1)

Countries

Germany (3)  ·  Switzerland (2)

Top investigators

Lars E French, MD (1)  ·  R Dummer, PrMD (1)

Results publications

PMID 26527564